EP3694942B1 - Cure accelerators for anaerobic curable compositions - Google Patents

Cure accelerators for anaerobic curable compositions Download PDF

Info

Publication number
EP3694942B1
EP3694942B1 EP18782443.8A EP18782443A EP3694942B1 EP 3694942 B1 EP3694942 B1 EP 3694942B1 EP 18782443 A EP18782443 A EP 18782443A EP 3694942 B1 EP3694942 B1 EP 3694942B1
Authority
EP
European Patent Office
Prior art keywords
cure
accelerator
anaerobic
composition according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18782443.8A
Other languages
German (de)
French (fr)
Other versions
EP3694942A1 (en
Inventor
David Birkett
Pat O'dwyer
David Condron
Hilary MONGEY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel IP and Holding GmbH
Original Assignee
Henkel IP and Holding GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel IP and Holding GmbH filed Critical Henkel IP and Holding GmbH
Publication of EP3694942A1 publication Critical patent/EP3694942A1/en
Application granted granted Critical
Publication of EP3694942B1 publication Critical patent/EP3694942B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C08K5/3432Six-membered rings
    • C08K5/3437Six-membered rings condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/20Esters of polyhydric alcohols or polyhydric phenols, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/04Acids, Metal salts or ammonium salts thereof
    • C08F20/06Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0025Crosslinking or vulcanising agents; including accelerators
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/005Stabilisers against oxidation, heat, light, ozone
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/07Aldehydes; Ketones
    • C08K5/08Quinones
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/14Peroxides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04Homopolymers or copolymers of esters
    • C08L33/06Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04Homopolymers or copolymers of esters
    • C09J133/06Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04Homopolymers or copolymers of esters
    • C09J133/14Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J4/00Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere
    • C09K3/10Materials in mouldable or extrudable form for sealing or packing joints or covers
    • C09K2003/1034Materials or components characterised by specific properties
    • C09K2003/1065Anaerobically hardenable materials

Definitions

  • the present invention relates to cure accelerators useful for anaerobic curable compositions, such as adhesives and sealants.
  • Anaerobic adhesive compositions generally are well-known. See e.g. R.D. Rich, "Anaerobic Adhesives” in Handbook of Adhesive Technology, 29, 467-79, A. Pizzi and K.L. Mittal, eds., Marcel Dekker, Inc., New York (1994 ), and references cited therein. Their uses are legion and new applications continue to be developed.
  • anaerobic adhesives ordinarily include a free-radically polymerizable acrylate ester monomer, together with a peroxyl initiator and an inhibitor component. Often, such anaerobic adhesive compositions also contain accelerator components to increase the speed with which the composition cures.
  • Desirable anaerobic cure-inducing compositions to induce and accelerate cure may ordinarily include one or more of saccharin, toluidines, such as N,N-diethyl-p-toluidine (“DE-p-T”) and N,N-dimethyl-o-toluidine (“DM-o-T”), acetyl phenylhydrazine (“APH”), maleic acid.
  • toluidines such as N,N-diethyl-p-toluidine (“DE-p-T") and N,N-dimethyl-o-toluidine (“DM-o-T”)
  • APH acetyl phenylhydrazine
  • Saccharin and APH are used as standard cure accelerator components in anaerobic adhesive cure systems. These components however have come under regulatory scrutiny in certain parts of the world, and thus efforts have been undertaken to identify candidates as replacements.
  • Examples of other curatives for anaerobic adhesives include thiocaprolactam (e.g. , U.S. Patent No. 5,411,988 ) and thioureas [ e.g. , U.S. Patent No. 3,970,505 (Hauser) (tetramethyl thiourea), German Patent Document Nos. DE 1 817 989 (alkyl thioureas and N,N'-dicyclohexyl thiourea) and 2 806 701 (ethylene thiourea), and Japanese Patent Document No. JP 07-308,757 (acyl, alkyl, alkylidene, alkylene and alkyl thioureas)], certain of the latter of which had been used commercially up until about twenty years ago.
  • thiocaprolactam e.g. , U.S. Patent No. 5,411,988
  • thioureas e.g. , U.S. Patent No. 3,970
  • Loctite (R&D) Ltd. discovered a new class of materials -- trithiadiaza pentalenes -- effective as curatives for anaerobic adhesive compositions.
  • the addition of these materials into anaerobic adhesives as a replacement for conventional curatives (such as APH) surprisingly provides at least comparable cure speeds and physical properties for the reaction products formed therefrom. See U.S. Patent No. 6,583,289 (McArdle ).
  • U.S. Patent No. 6,897,277 provides an anaerobic curable composition based on a (meth)acrylate component with an anaerobic cure-inducing composition substantially free of saccharin and an anaerobic cure accelerator compound within the following structure where R is selected from hydrogen, halogen, alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, carboxyl, and sulfonate, and R 1 is selected from hydrogen, alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, and alkaryl, an example of which is phenyl glycine and N-methyl phenyl glycine.
  • U.S. Patent No. 6,958,368 provides an anaerobic curable composition.
  • Examples of the anaerobic cure accelerator compound embraced by the structure above include 2-sulfobenzoic acid cyclic anhydride, and 3H-1,
  • THQ tetrahydroquinoline
  • U.S. Patent No. 8,362,112 describes a reaction product prepared from reactants comprising: (a) a compound embraced within where X is C 1-20 alkyl, C 2-20 alkenyl, or C 7-20 alkaryl, any of which may be interrupted by one or more hereto atoms, and which are functionalized by at least one group selected from -OH, -NH 2 or-SH and z is 1-3 and (b) at least one isocyanate functional material.
  • U.S. Patent No. 8,481,659 describes an anaerobic curable composition comprising (a) a (meth)acrylate component; (b) an anaerobic cure system; and (c) a reaction product prepared from reactants comprising: (i) at least one compound selected from the group of compounds represented by where z is 1-3; and (b) either: (i) at least one compound selected from the group of compounds represented by where Z" is selected from -O-, -S-, and -NH-; q is 1 to 4; R 6 is independently selected from the group consisting of hydroxyalkyl, aminoalkyl, and thioalkyl; and n is at least 1, where the reaction product comprises at least two pendant functional groups independently selected from -OH, -NH 2 and -SH; or (ii) an alkylating agent, alkenylating agent or alkarylating agent.
  • the present invention relates to cure accelerators useful for anaerobic curable compositions, such as adhesives and sealants.
  • R is hydrogen, alkyl, alkenyl, alkynl, hydroxyalkyl, hydroxyalkenyl, or hydroxyalkynl;
  • R 1 - R 6 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl;
  • R 7 is hydrogen or CHR 8 R 9 , where R 8 and R 9 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and
  • n is 0 or 1.
  • Each of the carboxyl, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl should contain as appropriate one to twelve carbon atoms.
  • a particularly desirable example is 1,2,3,4-tetrahydrobenzo-h-quinolin-3-ol.
  • the present invention relates to the addition of cure accelerators into anaerobic adhesives as a replacement for some or all of the amount of conventional anaerobic cure accelerators [such as toluidines, THQ and/or acetyl phenylhydrazine ("APH”)] surprisingly provides at least comparable cure speeds and physical properties for the reaction products formed therefrom, as compared with those observed from conventional anaerobic curable compositions.
  • conventional anaerobic cure accelerators such as toluidines, THQ and/or acetyl phenylhydrazine ("APH")
  • Suitable monomers include polyacrylate esters represented by the formula where R 4 is a radical selected from hydrogen, halogen or alkyl of from 1 to about 4 carbon atoms; q is an integer equal to at least 1, and preferably equal to from 1 to about 4; and X is an organic radical containing at least two carbon atoms and having a total bonding capacity of q plus 1.
  • R 4 is a radical selected from hydrogen, halogen or alkyl of from 1 to about 4 carbon atoms
  • q is an integer equal to at least 1, and preferably equal to from 1 to about 4
  • X is an organic radical containing at least two carbon atoms and having a total bonding capacity of q plus 1.
  • workable monomers exist at essentially any value. As a practical matter, however, a general upper limit is about 50 carbon atoms, preferably 30, and most preferably about 20.
  • Examples of useful acrylate ester oligomers include those having the following general formula: where R 5 represents a radical selected from hydrogen, lower alkyl of from 1 to about 4 carbon atoms, hydroxy alkyl of from 1 to about 4 carbon atoms, and where R 4 is a radical selected from hydrogen, halogen, or lower alkyl of from 1 to about 4 carbon atoms; R 6 is a radical selected from hydrogen, hydroxyl, or m is an integer equal to at least 1, e.g. , from 1 to about 15 or higher, and preferably from 1 to about 8; n is an integer equal to at least 1, e.g. , 1 to about 40 or more, and preferably between about 2 and about 10; and p is 0 or 1.
  • acrylate ester oligomers corresponding to the above general formula include di-, tri- and tetraethyleneglycol dimethacrylate; di(pentamethyleneglycol)dimethacrylate; tetraethyleneglycol diacrylate; tetraethyleneglycol di(chloroacrylate); diglycerol diacrylate; diglycerol tetramethacrylate; butyleneglycol dimethacrylate; neopentylglycol diacrylate; and trimethylolpropane triacrylate.
  • Another useful class of monomers is prepared by the reaction of a monofunctionally substituted alkyl or aryl acrylate ester containing an active hydrogen atom on the functional substituent. This monofunctional, acrylate-terminated material is reacted with an organic polyisocyanate in suitable proportions so as to convert all of the isocyanate groups to urethane or ureido groups.
  • the monofunctional alkyl and aryl acrylate esters are preferably the acrylates and methacrylates containing hydroxy or amino functional groups on the non-acrylate portion thereof.
  • Suitable hydroxyl-functional (meth)acrylate examples include hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl acrylate, hydroxyethyl methacrylate (“HEMA”), hydroxypropyl methacrylate (“HPMA”), hydroxybutyl methacrylate and mixtures thereof.
  • suitable hydroxy functional (meth)acrylates include 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxyethyl methacrylate (“HEMA”), pentaerythritol triacrylate (“PETA”), and 4-hydroxybutyl acrylate.
  • the (meth)acrylate component can comprise from about 10 to about 90 percent by weight of the composition, such as about 60 to about 90 percent by weight, based on the total weight of the composition.
  • one embodiment of the cure accelerator is where R, R 1 and R 2 are as defined above.
  • R is as defined above.
  • a particularly desirable embodiment is 1,2,3,4-tetrahydrobenzo-h-quinolin-3-ol
  • inventive compositions may also include other conventional components, such as free radical initiators, free radical co-accelerators, and inhibitors of free radical generation, as well as metal catalysts.
  • a number of well-known initiators of free radical polymerization are typically incorporated into the inventive compositions including, without limitation, peroxide compounds such as hydroperoxides, like cumene hydroperoxide (“CHP”), para-menthane hydroperoxide, t-butyl hydroperoxide (“TBH”) and t-butyl perbenzoate.
  • peroxide compounds such as hydroperoxides, like cumene hydroperoxide (“CHP”), para-menthane hydroperoxide, t-butyl hydroperoxide (“TBH”) and t-butyl perbenzoate.
  • peroxides include benzoyl peroxide, dibenzoyl peroxide, 1,3-bis(t-butylperoxyisopropyl)benzene, diacetyl peroxide, butyl 4,4-bis(t-butylperoxy)valerate, p-chlorobenzoyl peroxide, t-butyl cumyl peroxide, t-butyl perbenzoate, di-t-butyl peroxide, dicumyl peroxide, 2,5-dimethyl-2,5-di-t-butylperoxyhexane, 2,5-dimethyl-2,5-di-t-butyl-peroxyhex-3-yne, 4-methyl-2,2-di-t-butylperoxypentane and combinations thereof.
  • Such peroxide compounds are typically employed in the present invention in the range of from about 0.1 to about 10 percent by weight, based on the total weight of the composition, with about 1 to about 5 percent by weight being desirable.
  • accelerators of free radical polymerization may also be used in conjunction with the cure accelerators used in the present invention, though in amounts less than that used in the past.
  • Such accelerators are typically of the hydrazine variety (e.g. , APH), as disclosed in U.S. Patent Nos. 4,287,350 (Rich ) and 4,321,349 (Rich ).
  • APH hydrazine variety
  • maleic acid would usually be added as well.
  • inventive anaerobic cure accelerators render the use of such acids unnecessary in preparing anaerobic adhesive compositions.
  • co-accelerators may also be used in the compositions of the present invention including, without limitation, organic amides and imides, such as benzoic sulfimide (also known as saccharin) (see U.S. Patent No. 4,324,349 ).
  • benzoic sulfimide also known as saccharin
  • THQ as well could be used as a co-accelerator.
  • Stabilizers and inhibitors such as phenols including hydroquinone and quinones
  • Stabilizers and inhibitors may also be employed to control and prevent premature peroxide decomposition and polymerization of the composition of the present invention, as well as chelating agents [such as the tetrasodium salt of ethylenediamine tetraacetic acid ("EDTA”)] to trap trace amounts of metal contaminants therefrom.
  • chelating agents may ordinarily be present in the compositions in an amount from about 0.001 percent by weight to about 0.1 percent by weight, based on the total weight of the composition.
  • Metal catalyst solutions or pre-mixes thereof are used in amounts of about 0.03 to about 0.1 percent by weight.
  • additives such as thickeners, non-reactive plasticizers, fillers, toughening agents (such as elastomers and rubbers) and other well-known additives may be incorporated therein where the art-skilled believes it would be desirable to do so.
  • the present invention also provides methods of preparing and using the inventive anaerobic adhesive compositions, as well as reaction products of the compositions.
  • compositions of the present invention may be prepared using conventional methods which are well known to those persons of skill in the art.
  • the components of the inventive compositions may be mixed together in any convenient order consistent with the roles and functions the components are to perform in the compositions.
  • Conventional mixing techniques using known apparatus may be employed.
  • the present invention provides a method of using an anaerobic cure accelerator compound, including (I) mixing the anaerobic cure accelerator compound in an anaerobic curable composition or (II) applying onto a surface of a substrate the anaerobic cure accelerator compound and applying thereover an anaerobic curable composition.
  • an anaerobic cure accelerator compound including (I) mixing the anaerobic cure accelerator compound in an anaerobic curable composition or (II) applying onto a surface of a substrate the anaerobic cure accelerator compound and applying thereover an anaerobic curable composition.
  • the present invention also provides a bond formed between mated substrates with the inventive composition.
  • the components were mixed using a stainless steel propeller-type mixer.
  • Sample B (with THBQol) performed in most cases at least as well as the control, Sample A. See FIGs. 11-13 for a graphical depiction of these data.
  • FIGs. 1-6 show some of the data captured in Table 3 and also data from additional samples using THBQol in five different amounts (and none) as set forth below in Table 4.
  • Table 4 THBQol (Wt. %) Substrate/24 hour Breakaway Torque (N.m) BO & MS Brass ZnDiCr SS 1 34.42 10.16 17.76 9.88 0.5 28.82 11.72 15.18 9.88 0.25 30.30 8.50 14.90 5.76 0.1 28.96 9.66 16.02 7.26 0.01 29.52 9.48 12.60 11.38 0 (Sample A) 38.08 16.24 12.70 7.92
  • Sample A uses THQ in an amount of 1 percent by weight, it is apparent from the data recorded in Tables 4 and 5 that the use of THBQol instead may produce at least acceptable performance in many cases at levels as low as 0.1 percent by weight. See also FIGs. 1 and 2 for a graphical depiction of this data.
  • Anaerobic curable compositions with THBQol as an accelerator displayed excellent cure through gap performance on mild steel pin and collars at 0.15 mm gap after 24 hour cure in amounts ranging from 0.1 to 1 percent by weight. See FIG. 7 .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Epoxy Resins (AREA)
  • Polymerization Catalysts (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Description

    BACKGROUND Field
  • The present invention relates to cure accelerators useful for anaerobic curable compositions, such as adhesives and sealants. The cure accelerators are embraced within the structure below
    Figure imgb0001
    where X is CH2, O, S, NR4, CR5R6 or C=O; R is hydrogen, alkyl, alkenyl, alkynl, hydroxyalkyl, hydroxyalkenyl, or hydroxyalkynl; R1 - R6 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; R7 is hydrogen or CHR8R9, where R8 and R9 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and n is 0 or 1. A particularly desirable example is 1,2,3,4-tetrahydrobenzo-h-quinolin-3-ol.
  • Brief Description of Related Technology
  • Anaerobic adhesive compositions generally are well-known. See e.g. R.D. Rich, "Anaerobic Adhesives" in Handbook of Adhesive Technology, 29, 467-79, A. Pizzi and K.L. Mittal, eds., Marcel Dekker, Inc., New York (1994), and references cited therein. Their uses are legion and new applications continue to be developed.
  • Conventional anaerobic adhesives ordinarily include a free-radically polymerizable acrylate ester monomer, together with a peroxyl initiator and an inhibitor component. Often, such anaerobic adhesive compositions also contain accelerator components to increase the speed with which the composition cures.
  • Desirable anaerobic cure-inducing compositions to induce and accelerate cure may ordinarily include one or more of saccharin, toluidines, such as N,N-diethyl-p-toluidine ("DE-p-T") and N,N-dimethyl-o-toluidine ("DM-o-T"), acetyl phenylhydrazine ("APH"), maleic acid.
  • Saccharin and APH are used as standard cure accelerator components in anaerobic adhesive cure systems. These components however have come under regulatory scrutiny in certain parts of the world, and thus efforts have been undertaken to identify candidates as replacements.
  • Examples of other curatives for anaerobic adhesives include thiocaprolactam (e.g., U.S. Patent No. 5,411,988 ) and thioureas [e.g., U.S. Patent No. 3,970,505 (Hauser) (tetramethyl thiourea), German Patent Document Nos. DE 1 817 989 (alkyl thioureas and N,N'-dicyclohexyl thiourea) and 2 806 701 (ethylene thiourea), and Japanese Patent Document No. JP 07-308,757 (acyl, alkyl, alkylidene, alkylene and alkyl thioureas)], certain of the latter of which had been used commercially up until about twenty years ago.
  • Loctite (R&D) Ltd. discovered a new class of materials -- trithiadiaza pentalenes -- effective as curatives for anaerobic adhesive compositions. The addition of these materials into anaerobic adhesives as a replacement for conventional curatives (such as APH) surprisingly provides at least comparable cure speeds and physical properties for the reaction products formed therefrom. See U.S. Patent No. 6,583,289 (McArdle ).
  • U.S. Patent No. 6,835,762 (Klemarczyk ) provides an anaerobic curable composition based on a (meth)acrylate component with an anaerobic cure-inducing composition substantially free of acetyl phenylhydrazine and maleic acid and an anaerobic cure accelerator compound having the linkage - C(=O)-NH-NH- and an organic acid group on the same molecule, provided the anaerobic cure accelerator compound excludes 1-(2-carboxyacryloyl)-2-phenylhydrazine. The anaerobic cure accelerator is embraced by:
    Figure imgb0002
    where R1-R7 are each independently selected from hydrogen and C1-4; Z is a carbon-carbon single bond or carbon-carbon double bond; q is 0 or 1; and p is an integer between 1 and 5, examples of which are 3-carboxyacryloyl phenylhydrazine, methyl-3-carboxyacryloyl phenylhydrazine, 3-carboxypropanoyl phenylhydrazine, and methylene-3-carboxypropanoyl phenylhydrazine.
  • U.S. Patent No. 6,897,277 (Klemarczyk ) provides an anaerobic curable composition based on a (meth)acrylate component with an anaerobic cure-inducing composition substantially free of saccharin and an anaerobic cure accelerator compound within the following structure
    Figure imgb0003
    where R is selected from hydrogen, halogen, alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, carboxyl, and sulfonate, and R1 is selected from hydrogen, alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, and alkaryl, an example of which is phenyl glycine and N-methyl phenyl glycine.
  • U.S. Patent No. 6,958,368 (Messana ) provides an anaerobic curable composition. This composition is based on a (meth)acrylate component with an anaerobic cure-inducing composition substantially free of saccharin and within the following structure
    Figure imgb0004
    where Y is an aromatic ring, optionally substituted at up to five positions by C1-6 alkyl or alkoxy, or halo groups; A is C=O, S=O or O=S=O; X is NH, O or S and Z is an aromatic ring, optionally substituted at up to five positions by C1-6 alkyl or alkoxy, or halo groups, or Y and Z taken together may join to the same aromatic ring or aromatic ring system, provided that when X is NH, o-benzoic sulfimide is excluded from the structure. Examples of the anaerobic cure accelerator compound embraced by the structure above include 2-sulfobenzoic acid cyclic anhydride, and 3H-1,2-benzodithiol-3-one-1,1-dioxide.
  • Three Bond Co. Ltd., Tokyo, Japan has in the past described as a component in anaerobic adhesive and sealant compositions a component called tetrahydroquinoline ("THQ").
  • And more recently U.S. Patent No. 8,362,112 describes a reaction product prepared from reactants comprising: (a) a compound embraced within
    Figure imgb0005
    where X is C1-20 alkyl, C2-20 alkenyl, or C7-20 alkaryl, any of which may be interrupted by one or more hereto atoms, and which are functionalized by at least one group selected from -OH, -NH2 or-SH and z is 1-3 and (b) at least one isocyanate functional material.
  • U.S. Patent No. 8,481,659 describes an anaerobic curable composition comprising (a) a (meth)acrylate component; (b) an anaerobic cure system; and (c) a reaction product prepared from reactants comprising: (i) at least one compound selected from the group of compounds represented by
    Figure imgb0006
    where z is 1-3; and (b) either: (i) at least one compound selected from the group of compounds represented by
    Figure imgb0007
    where Z" is selected from -O-, -S-, and -NH-; q is 1 to 4; R6 is independently selected from the group consisting of hydroxyalkyl, aminoalkyl, and thioalkyl; and n is at least 1, where the reaction product comprises at least two pendant functional groups independently selected from -OH, -NH2 and -SH; or (ii) an alkylating agent, alkenylating agent or alkarylating agent.
  • Notwithstanding the state of the art, there is an ongoing desire to find alternative technologies for anaerobic cure accelerators to differentiate existing products and provide supply assurances in the event of shortages or cessation of supply of raw materials. Moreover, since certain of the raw materials used in conventional anaerobic cure inducing compositions have to one degree or another come under regulatory scrutiny and may be affected by supply chain interruptions, alternative components for anaerobic cure inducing compositions would be desirable. Accordingly, it would be desirable to identify new materials that function as cure components in the cure of anaerobically curable compositions.
  • SUMMARY
  • The present invention relates to cure accelerators useful for anaerobic curable compositions, such as adhesives and sealants.
  • The cure accelerators are embraced within the structure below
    Figure imgb0008
    where X is CH2, O, S, NR4, CR5R6 or C=O; R is hydrogen, alkyl, alkenyl, alkynl, hydroxyalkyl, hydroxyalkenyl, or hydroxyalkynl; R1 - R6 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; R7 is hydrogen or CHR8R9, where R8 and R9 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and n is 0 or 1. Each of the carboxyl, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl should contain as appropriate one to twelve carbon atoms. A particularly desirable example is 1,2,3,4-tetrahydrobenzo-h-quinolin-3-ol.
  • These cure accelerators are useful in anaerobic curable compositions that comprise a (meth)acrylate component and an anaerobic cure-inducing component.
  • BRIEF DESCRIPTION OF THE FIGURES
    • FIG. 1 depicts a plot of 24 hour breakaway torque of anaerobic adhesive compositions as a control (that contains 0.9% by weight THQ as an accelerator) and a comparable one without THQ but with THBQol as an inventive cure accelerator at various concentrations, on M10 nuts and bolts constructed from brass, zinc dichromate, stainless and mild steel/black oxide.
    • FIG. 2 depicts a plot of 24 hour prevail torque of anaerobic adhesive compositions as a control (that contains 0.9% by weight THQ as an accelerator) and a comparable one without THQ but with THBQol as an inventive cure accelerator at various concentrations, on M10 nuts and bolts constructed from brass, zinc dichromate, stainless and mild steel/black oxide.
    • FIG. 3 depicts a plot of 1 hour breakaway torque of anaerobic adhesive compositions as a control (that contains 0.9% by weight THQ as an accelerator) and a comparable one without THQ but with THBQol as an inventive cure accelerator at various concentrations, on M10 nuts and bolts constructed from brass, zinc dichromate, stainless and mild steel/black oxide.
    • FIG. 4 depicts a plot of 1 hour prevail torque of anaerobic adhesive compositions as a control (that contains 0.9% by weight THQ as an accelerator) and a comparable one without THQ but with THBQol as an inventive cure accelerator at various concentrations, on M10 nuts and bolts constructed from brass, zinc dichromate, stainless and mild steel/black oxide.
    • FIG. 5 depicts a plot of 24 hour shear strength of anaerobic adhesive compositions as a control (that contains 0.9% by weight THQ as an accelerator) and a comparable one without THQ but with THBQol as an inventive cure accelerator at various concentrations, on pin and collars constructed from mild steel.
    • FIG. 6 depicts a plot of 1 hour shear strength of anaerobic adhesive compositions as a control (that contains 0.9% by weight THQ as an accelerator) and a comparable one without THQ but with THBQol as an inventive cure accelerator at various concentrations, on pin and collars constructed from mild steel.
    • FIG. 7 depicts a plot of 24 hour shear strength of anaerobic adhesive compositions as a control (that contains 0.9% by weight THQ as an accelerator) and a comparable one without THQ but with THBQol as an inventive cure accelerator at various concentrations, on pin and collars constructed from mild steel set with a gap of 0.15 mmm between the pin and collar.
    • FIG. 8 depicts a bar chart of shear strength values for Samples C and D after 1 and 24 hour cure.
    • FIG. 9 depicts a bar chart of breakaway torque values for Samples C and D after 0.5 and 24 hour cure.
    • FIG. 10 depicts a bar chart of prevail torque values for Samples C and D after 0.5 and 24 hour cure.
    • FIG. 11 depicts a bar chart of shear strength values on pin and collar assemblies for Samples A and B after 1 and 24 hour cure.
    • FIG. 12 depicts a bar chart of breakaway torque values for Samples A and B after 1 and 24 hour cure.
    • FIG. 13 depicts a bar chart of prevail torque values for Samples A and B after 1 and 24 hour cure.
    DETAILED DESCRIPTION
  • The present invention relates to the addition of cure accelerators into anaerobic adhesives as a replacement for some or all of the amount of conventional anaerobic cure accelerators [such as toluidines, THQ and/or acetyl phenylhydrazine ("APH")] surprisingly provides at least comparable cure speeds and physical properties for the reaction products formed therefrom, as compared with those observed from conventional anaerobic curable compositions.
  • For instance, through the use of the inventive cure accelerator reduced levels of THQ and/or APH (such as about 50% or less by weight of that which is used in conventional anaerobic curable compositions), may be achieved and desirably the anaerobic curable compositions are substantially free of THQ and/or APH (less than about 10 weight percent, less than about 5 weight percent or less than about 1 weight percent) or is free of THQ and/or APH. In place of some or all of THQ and/or APH is the cure accelerator of the present invention.
  • (Meth)acrylate monomers suitable for use as the (meth)acrylate component in the present invention may be selected from a wide variety of materials, such as those represented by H2C=CGCO2R8, where G may be hydrogen, halogen or alkyl groups having from 1 to about 4 carbon atoms, and R8 may be selected from alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkaryl, aralkyl or aryl groups having from 1 to about 16 carbon atoms, any of which may be optionally substituted or interrupted as the case may be with silane, silicon, oxygen, halogen, carbonyl, hydroxyl, ester, carboxylic acid, urea, urethane, carbonate, amine, amide, sulfur, sulfonate, sulfone and the like.
  • Additional (meth)acrylate monomers suitable for use herein as the (meth)acrylate component in the present invention or as a component in making the reaction product include polyfunctional (meth)acrylate monomers, for example di-or trifunctional (meth)acrylates such as polyethylene glycol di(meth)acrylates, tetrahydrofuran (meth)acrylates and di(meth)acrylates, hydroxypropyl (meth)acrylate ("HPMA"), hexanediol di(meth)acrylate, trimethylol propane tri(meth)acrylates ("TMPTMA"), diethylene glycol dimethacrylate, triethylene glycol dimethacrylates ("TRIEGMA"), tetraethylene glycol di(meth)acrylates, dipropylene glycol di(meth)acrylates, di-(pentamethylene glycol) di(meth)acrylates, tetraethylene diglycol di(meth)acrylates, diglycerol tetra(meth)acrylates, tetramethylene di(meth)acrylates, ethylene di(meth)acrylates, neopentyl glycol di(meth)acrylates, and bisphenol-A mono and di(meth)acrylates, such as ethoxylated bisphenol-A (meth)acrylate ("EBIPMA"), and bisphenol-F mono and di(meth)acrylates, such as ethoxylated bisphenol-A (meth)acrylate.
  • Still other (meth)acrylate monomers that may be used herein include silicone (meth)acrylate moieties ("SiMA"), such as those taught by and claimed in U.S. Patent No. 5,605,999 (Chu ).
  • Other suitable monomers include polyacrylate esters represented by the formula
    Figure imgb0009
    where R4 is a radical selected from hydrogen, halogen or alkyl of from 1 to about 4 carbon atoms; q is an integer equal to at least 1, and preferably equal to from 1 to about 4; and X is an organic radical containing at least two carbon atoms and having a total bonding capacity of q plus 1. With regard to the upper limit for the number of carbon atoms in X, workable monomers exist at essentially any value. As a practical matter, however, a general upper limit is about 50 carbon atoms, preferably 30, and most preferably about 20.
  • For example, X can be an organic radical of the formula:
    Figure imgb0010
    wherein each of Y1 and Y2 is an organic radical, preferably a hydrocarbon group, containing at least 2 carbon atoms, and preferably from 2 to about 10 carbon atoms, and Z is an organic radical, preferably a hydrocarbon group, containing at least 1 carbon atom, and preferably from 2 to about 10 carbon atoms.
  • Other classes of useful monomers are the reaction products of di- or tri-alkylolamines (e.g., ethanolamines or propanolamines) with acrylic acids, such as are disclosed in French Patent No. 1,581,361 .
  • Examples of useful acrylate ester oligomers include those having the following general formula:
    Figure imgb0011
    where R5 represents a radical selected from hydrogen, lower alkyl of from 1 to about 4 carbon atoms, hydroxy alkyl of from 1 to about 4 carbon atoms, and
    Figure imgb0012
    where R4 is a radical selected from hydrogen, halogen, or lower alkyl of from 1 to about 4 carbon atoms; R6 is a radical selected from hydrogen, hydroxyl, or
    Figure imgb0013
    m is an integer equal to at least 1, e.g., from 1 to about 15 or higher, and preferably from 1 to about 8; n is an integer equal to at least 1, e.g., 1 to about 40 or more, and preferably between about 2 and about 10; and p is 0 or 1.
  • Typical examples of acrylate ester oligomers corresponding to the above general formula include di-, tri- and tetraethyleneglycol dimethacrylate; di(pentamethyleneglycol)dimethacrylate; tetraethyleneglycol diacrylate; tetraethyleneglycol di(chloroacrylate); diglycerol diacrylate; diglycerol tetramethacrylate; butyleneglycol dimethacrylate; neopentylglycol diacrylate; and trimethylolpropane triacrylate.
  • While di- and other polyacrylate esters, and particularly the polyacrylate esters described in the preceding paragraphs, can be desirable, monofunctional acrylate esters (esters containing one acrylate group) also may be used. When dealing with monofunctional acrylate esters, it is highly preferable to use an ester which has a relatively polar alcoholic moiety. Such materials are less volatile than low molecular weight alkyl esters and, more important, the polar group tends to provide intermolecular attraction during and after cure, thus producing more desirable cure properties, as well as a more durable sealant or adhesive. Desirably, the polar group is selected from labile hydrogen, heterocyclic ring, hydroxy, amino, cyano, and halo polar groups. Typical examples of compounds within this category are cyclohexylmethacrylate, tetrahydrofurfuryl methacrylate, hydroxyethyl acrylate, hydroxypropyl methacrylate, t-butylaminoethyl methacrylate, cyanoethylacrylate, and chloroethyl methacrylate.
  • Another useful class of monomers is prepared by the reaction of a monofunctionally substituted alkyl or aryl acrylate ester containing an active hydrogen atom on the functional substituent. This monofunctional, acrylate-terminated material is reacted with an organic polyisocyanate in suitable proportions so as to convert all of the isocyanate groups to urethane or ureido groups. The monofunctional alkyl and aryl acrylate esters are preferably the acrylates and methacrylates containing hydroxy or amino functional groups on the non-acrylate portion thereof. Acrylate esters suitable for use have the formula
    Figure imgb0014
    where X is selected from --O-- or
    Figure imgb0015
    and R9 is selected from hydrogen or lower alkyl of 1 through 7 carbon atoms; R7 is selected from hydrogen, chlorine or methyl and ethyl radicals; and R8 is a divalent organic radical selected from lower alkylene of 1 through 8 carbon atoms, phenylene or naphthylene. These groups upon proper reaction with a polyisocyanate, yield a monomer of the following general formula:
    Figure imgb0016
    where n is an integer from 2 to about 6; B is a polyvalent organic radical selected from alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, aralkyl, alkaryl or heterocyclic radicals both substituted and unsubstituted; and R7, R8 and X have the meanings given above.
  • Examples of suitable hydroxyl-functional (meth)acrylate include hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl acrylate, hydroxyethyl methacrylate ("HEMA"), hydroxypropyl methacrylate ("HPMA"), hydroxybutyl methacrylate and mixtures thereof. Other examples of suitable hydroxy functional (meth)acrylates include 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxyethyl methacrylate ("HEMA"), pentaerythritol triacrylate ("PETA"), and 4-hydroxybutyl acrylate.
  • The hydroxy-functional (meth)acrylate can have a number average molecular weight of about 80 to about 1,000 grams/mole, or about 100 to about 800 grams/mole, or about 110 to about 600 grams/mole.
  • Of course, combinations of these (meth)acrylate monomers may also be used.
  • The (meth)acrylate component can comprise from about 10 to about 90 percent by weight of the composition, such as about 60 to about 90 percent by weight, based on the total weight of the composition.
  • The anaerobic cure-inducing composition comprises a hydroperoxide selected from t-butyl hydroperoxide, p-methane hydroperoxide, cumene hydroperoxide, diisopropylbenzene hydroperoxide, and mixtures thereof.
  • As noted above, cure accelerators are provided embraced within the structure below
    Figure imgb0017
    where X is CH2, O, S, NR4, CR5R6 or C=O; R is hydrogen, alkyl, alkenyl, alkynl, hydroxyalkyl, hydroxyalkenyl, or hydroxyalkynl; R1 - R6 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; R7 is hydrogen or CHR8R9, where R8 and R9 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and n is 0 or 1. Each of the carboxyl, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl should contain as appropriate one to twelve carbon atoms.
  • More specifically, one embodiment of the cure accelerator is
    Figure imgb0018
    where R, R1 and R2 are as defined above.
  • And within the structures above are desirable alternative embodiments of the cure accelerator:
    Figure imgb0019
    Figure imgb0020
    In each of these three alternative embodiments, R is as defined above.
  • A particularly desirable embodiment is
    Figure imgb0021
    1,2,3,4-tetrahydrobenzo-h-quinolin-3-ol
  • The cure accelerator may be present in amounts of about 0.005 to about 5 percent by weight, such as about 0.01 to about 2 percent by weight desirably about 0.01 to about 1.5 percent by weight, based on the total weight of the composition. The cure accelerators may be used in combination with conventional accelerators (here called co-accelerators though at lower levels than such conventional accelerators).
  • To the (meth)acrylate component, the anaerobic cure-inducing composition and the cure accelerator may be added components that have been included in traditional anaerobic adhesives to alter the physical properties of either the formulation or the reaction products thereof. For instance, one or more of maleimide components, thermal resistance-conferring co reactants, diluent components reactive at elevated temperature conditions, mono- or poly-hydroxyalkanes, polymeric plasticizers, and chelators (see U.S. Patent No. 6,391,993 ) may be included to modify the physical property and/or cure profile of the formulation and/or the strength or temperature resistance of the cured adhesive.
  • When used, the maleimide, co-reactant, reactive diluent, plasticizer, and/or mono- or poly-hydroxyalkanes, may be present in an amount within the range of about 1 percent to about 30 percent by weight, based on the total weight of the composition.
  • The inventive compositions may also include other conventional components, such as free radical initiators, free radical co-accelerators, and inhibitors of free radical generation, as well as metal catalysts.
  • A number of well-known initiators of free radical polymerization are typically incorporated into the inventive compositions including, without limitation, peroxide compounds such as hydroperoxides, like cumene hydroperoxide ("CHP"), para-menthane hydroperoxide, t-butyl hydroperoxide ("TBH") and t-butyl perbenzoate. Other peroxides include benzoyl peroxide, dibenzoyl peroxide, 1,3-bis(t-butylperoxyisopropyl)benzene, diacetyl peroxide, butyl 4,4-bis(t-butylperoxy)valerate, p-chlorobenzoyl peroxide, t-butyl cumyl peroxide, t-butyl perbenzoate, di-t-butyl peroxide, dicumyl peroxide, 2,5-dimethyl-2,5-di-t-butylperoxyhexane, 2,5-dimethyl-2,5-di-t-butyl-peroxyhex-3-yne, 4-methyl-2,2-di-t-butylperoxypentane and combinations thereof.
  • Such peroxide compounds are typically employed in the present invention in the range of from about 0.1 to about 10 percent by weight, based on the total weight of the composition, with about 1 to about 5 percent by weight being desirable.
  • As noted, conventional accelerators of free radical polymerization may also be used in conjunction with the cure accelerators used in the present invention, though in amounts less than that used in the past. Such accelerators (referred to herein as co-accelerators) are typically of the hydrazine variety (e.g., APH), as disclosed in U.S. Patent Nos. 4,287,350 (Rich ) and 4,321,349 (Rich ). When APH is chosen as a co-accelerator for use herein, maleic acid would usually be added as well. One benefit of the present invention is that the inventive anaerobic cure accelerators render the use of such acids unnecessary in preparing anaerobic adhesive compositions.
  • Other co-accelerators may also be used in the compositions of the present invention including, without limitation, organic amides and imides, such as benzoic sulfimide (also known as saccharin) (see U.S. Patent No. 4,324,349 ). Of course, THQ as well could be used as a co-accelerator.
  • Stabilizers and inhibitors (such as phenols including hydroquinone and quinones) may also be employed to control and prevent premature peroxide decomposition and polymerization of the composition of the present invention, as well as chelating agents [such as the tetrasodium salt of ethylenediamine tetraacetic acid ("EDTA")] to trap trace amounts of metal contaminants therefrom. When used, chelating agents may ordinarily be present in the compositions in an amount from about 0.001 percent by weight to about 0.1 percent by weight, based on the total weight of the composition.
  • Metal catalyst solutions or pre-mixes thereof are used in amounts of about 0.03 to about 0.1 percent by weight.
  • Other additives such as thickeners, non-reactive plasticizers, fillers, toughening agents (such as elastomers and rubbers) and other well-known additives may be incorporated therein where the art-skilled believes it would be desirable to do so.
  • The present invention also provides methods of preparing and using the inventive anaerobic adhesive compositions, as well as reaction products of the compositions.
  • The compositions of the present invention may be prepared using conventional methods which are well known to those persons of skill in the art. For instance, the components of the inventive compositions may be mixed together in any convenient order consistent with the roles and functions the components are to perform in the compositions. Conventional mixing techniques using known apparatus may be employed.
  • The compositions of this invention may be applied to a variety of substrates to perform with the desired benefits and advantages described herein. For instance, appropriate substrates may be constructed from steel, brass, copper, aluminum, zinc, and other metals and alloys, ceramics and thermosets. The compositions of this invention demonstrate particularly good bond strength on steel, brass, copper and zinc. An appropriate primer for anaerobic curable compositions may be applied to a surface of the chosen substrate to enhance cure rate. Or, the inventive anaerobic cure accelerators may be applied to the surface of a substrate as a primer. See e.g. U.S. Patent No. 5,811,473 (Ramos ).
  • In addition, the invention provides a method of preparing an anaerobic curable composition, a step of which includes mixing together a (meth)acrylate component, an anaerobic cure inducing composition, and an anaerobic cure accelerator reaction product.
  • And the present invention provides a method of using an anaerobic cure accelerator compound, including (I) mixing the anaerobic cure accelerator compound in an anaerobic curable composition or (II) applying onto a surface of a substrate the anaerobic cure accelerator compound and applying thereover an anaerobic curable composition. Of course, the present invention also provides a bond formed between mated substrates with the inventive composition.
  • In view of the above description of the present invention, it is clear that a wide range of practical opportunities are provided. The following examples are for illustrative purposes only, and are not to be construed so as to limit in any way the teaching herein.
  • EXAMPLES
  • The noted components in the amounts indicated in Table 1 below were used to formulate Samples B and D. As controls, Samples A and C, respectively, were used. Table 1
    Component Sample/Amt (wt%)
    A B C D
    PEG 200 Dimethacrylate 68.7 68.7 65.10 55.10
    Stabilizer 0.015 0.015 0.40 0.40
    Chelator 0.6 0.6 2.50 2.50
    26.5
    Organic Filler 26.5 20.00 20.00
    Saccharin 1.0 1.00 1.00 1.00
    Accelerator/THQ 0.9 -- 1.00 --
    Accelerator/THBQol -- 0.9 -- 1.00
    Initiator 0.9 0.9 0.9 0.9
  • In preparing the samples, the components were mixed using a stainless steel propeller-type mixer.
  • These samples were evaluated for a variety of strength measurements, including breakaway torque, prevail torque and shear strength, on a variety of substrates.
  • Breakaway torque is the initial torque required to decrease or eliminate the axial load in a non-seated assembly. Prevailing torque, after initial breakage of the bond, is measured at any point during 360° rotation of the nut. Prevailing torque is normally determined at 180° rotation of the nut.
  • Black oxide bolts and mild steel were degreased, adhesive was applied to the bolt, and the nut was screwed onto the bolt. Five nut and bolt specimens were assembled for each adhesive formulation tested. For the breakaway/prevail evaluation, the specimens were maintained at ambient temperature for 1 hour and 24 hours after assembly. The breakaway and prevail torque strengths (N-m) were then recorded for five specimens of each adhesive formulation after 1 hour and after 24 hours at ambient temperature (25°C) and 45-50% relative humidity, respectively. The torque strengths were measured using a calibrated automatic torque analyzer. The data for the breakaway torque evaluations is set forth in Tables 2A and 2B below. Table 2A
    Sample Time (hours)
    1 24
    Breakaway Torque (N-m)
    A 26 38
    B 35 34
    Table 2B
    Sample Time (hours)
    0.5 24
    Breakaway Torque (N-m)
    C 14 24
    D 17 32
  • This data captured in Tables 2A and 2B indicates that Samples B and D exhibited generally similar breakloose properties at room temperature compared to the controls (Samples A and C) when applied and cured on the substrates.
  • In Table 3 below, additional data was developed and recorded for Samples A and B. Table 3
    Physical Property Sample
    A B
    Shear Strength /Steel Pin and Collar, 1 hour 21 18
    Shear Strength /Steel Pin and Collar, 24 hours 19 19
    Breakaway Torque/M10 Black Oxide bolts and Mild Steel nuts, 1 hour 26 35
    Prevail Torque/M10 Black Oxide bolts and Mild Steel nuts, 1 hour 36 45
    Breakaway Torque/M10 Black Oxide bolts and Mild Steel nuts, 24 hours 38 34
    Prevail Torque/M10 Black Oxide bolts and Mild Steel nuts, 24 hours 45 45
  • Sample B (with THBQol) performed in most cases at least as well as the control, Sample A. See FIGs. 11-13 for a graphical depiction of these data.
  • Reference to FIGs. 1-6 show some of the data captured in Table 3 and also data from additional samples using THBQol in five different amounts (and none) as set forth below in Table 4. Table 4
    THBQol (Wt. %) Substrate/24 hour Breakaway Torque (N.m)
    BO & MS Brass ZnDiCr SS
    1 34.42 10.16 17.76 9.88
    0.5 28.82 11.72 15.18 9.88
    0.25 30.30 8.50 14.90 5.76
    0.1 28.96 9.66 16.02 7.26
    0.01 29.52 9.48 12.60 11.38
    0 (Sample A) 38.08 16.24 12.70 7.92
  • In Table 5 below, prevail torque measurements were captured for the samples noted in Table 4. Table 5
    THBQol (Wt. %) Substrate/24 hour Prevail Torque (N.m)
    BO & MS Brass ZnDiCr SS
    1 45.40 29.46 26.40 9.88
    0.5 47.74 35.26 26.16 25.24
    0.25 44.12 36.36 23.76 26.42
    0.1 45.00 37.90 20.48 32.42
    0.01 37.24 27.96 22.38 22.38
    0 (Sample A) 45.68 40.26 23.88 32.48
  • Bearing in mind that Sample A uses THQ in an amount of 1 percent by weight, it is apparent from the data recorded in Tables 4 and 5 that the use of THBQol instead may produce at least acceptable performance in many cases at levels as low as 0.1 percent by weight. See also FIGs. 1 and 2 for a graphical depiction of this data.
  • One hour breakaway and prevail strength measurements for these samples were also captured and recorded below in Tables 6 and 7. Table 6
    THBQol (Wt. %) Substrate/1 hour Breakaway Torque (N.m)
    BO & MS ZnDiCr Brass SS
    1 35.18 0.84 16.43 5.85
    0.5 35.52 4.74 14.64 7.90
    0.25 32.20 7.84 12.44 7.12
    0.1 29.28 5.42 10.83 7.60
    0.01 12.82 7.00 9.36 3.02
    0 (Sample A) 26.03 2.32 18.52 7.72
    Table 7
    THBQol (Wt. %) Substrate/1 hour Prevail Torque (N.m)
    BO & MS Brass SS ZnDiCr
    1 45.00 36.88 29.65 0.50
    0.5 41.32 32.92 30.08 14.62
    0.25 35.48 31.82 25.92 15.80
    0.1 33.82 31.14 29.10 15.76
    0.01 17.46 30.92 12.06 17.26
    0 (Sample A) 36.18 33.50 27.32 2.44
  • Like the 24 hour breakaway and prevail data, it is apparent from the 1 hour breakaway and prevail data recorded in Tables 6 and 7 that the use of THBQol instead may produce at least acceptable performance in many cases at levels as low as 0.1 percent by weight. See also FIGs. 3 and 4 for a graphical depiction of this data.
  • 24 hour cure performance of THBQol as a cure accelerator in an anaerobic curable composition five different amounts was also compared with Sample A (which had no THBQol, but rather 0.9 wt% THQ). The results are captured in Table 8 below. Table 8
    24 hour Cure, Mild Steel Pin and Collar
    THBQol (Wt. %) Shear Strength (N.mm-2)
    1 18.57
    0.5 20.08
    0.25 20.38
    0.1 17.70
    0.01 12.98
    0 (Sample A) 19.28
  • Anaerobic curable compositions with THBQol as an accelerator displayed excellent performance on mild steel pin and collars after 24 hour cure in amounts ranging from 0.1 to 1 percent by weight. See FIG. 5.
  • 1 hour cure performance of THBQol as a cure accelerator in an anaerobic curable composition five different amounts was also compared with Sample A (which had no THBQol, but rather 0.9 wt% THQ). The results are captured in Table 9 below. Table 9
    1 hour Cure, Mild Steel Pin and Collar
    THBQol (Wt. %) Shear Strength (N.mm-2)
    1 18.25
    0.5 20.53
    0.25 20.46
    0.1 17.93
    0.01 16.12
    0 (Sample A) 21.28
  • Anaerobic curable compositions with THBQol as an accelerator displayed excellent performance on mild steel pin and collars after 1 hour cure in amounts ranging from 0.1 to 1 percent by weight. See FIG. 6.
  • Cure through gap performance of THBQol as a cure accelerator in an anaerobic curable composition wat two different amounts as also compared with Sample A (which had no THBQol, but rather 0.9 wt% THQ). The results are captured in Table 10 below. Table 10
    24 hour, 0.15mm Gap Cure, Mild Steel Pin and Collar
    THBQol (Wt. %) Shear Strength (N.mm-2)
    1 3.13
    0.1 3.93
    0 (Sample A) 3.08
  • Anaerobic curable compositions with THBQol as an accelerator displayed excellent cure through gap performance on mild steel pin and collars at 0.15 mm gap after 24 hour cure in amounts ranging from 0.1 to 1 percent by weight. See FIG. 7.
  • THBQol was also compared with APH as a cure accelerator. Thus, instead of using Sample A as a control, Sample C was used as a control in the following evaluation, as it uses APH as a cure accelerator.
  • In Table 11, shear strength performance after 1 hour and 24 hours is captured for Samples C and D, as the average of five replicates on mild steel pin and collars having first been degreased. Table 11
    Physical Property Sample
    C D
    Shear Strength/Pin and Collar, 1 hour 11 11
    Shear Strength/Pin and Collar, 24 hours 13 13
  • This data indicates that shear strength performance of THBQol as an accelerator is at least comparable to APH on bonded mild steel parts. See FIG. 8 for a graphical depiction of the data.
  • In Table 12, breakaway torque performance after 30 minutes and 24 hours is captured for Samples C and B, as the average of five replicates on black oxide nuts and bolts having first been degreased. Table 12
    Physical Property Sample
    C D
    Breakaway Torque/M10 Black Oxide Nuts and Bolts, 30 minutes 15 17
    Breakaway Torque/M10 Black Oxide Nuts and Bolts, 24 hours 24 32
  • This data indicates that breakaway torque performance of THBQol as an accelerator is at least comparable to APH on bonded black oxide nuts and bolts. See FIG. 9 for a graphical depiction of the data.
  • In Table 13, prevail torque performance data is captured for Samples C and D, as the average of five replicates on black oxide nuts and bolts having first been degreased. Table 13
    Physical Property Sample
    C D
    Prevail Torque/M10 Black Oxide Nuts and Bolts, 30 minutes 1.6 2.3
    Prevail Torque/M10 Black Oxide Nuts and Bolts, 24 hours 3.4 5.7
  • This data indicates that breakaway torque performance of THBQol as an accelerator is at least comparable to APH on bonded black oxide nuts and bolts. See FIG. 10 for a graphical depiction of the data.

Claims (10)

  1. An anaerobic curable composition comprising:
    (a) a (meth)acrylate component;
    (b) an anaerobic cure-inducing composition; and
    (c) a cure accelerator embraced by
    Figure imgb0022
    wherein X is CH2, O, S, NR4, CR5R6 or C=O; R is hydrogen, alkyl, alkenyl, alkynl, hydroxyalkyl, hydroxyalkenyl, or hydroxyalkynl; R1 - R6 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; R7 is hydrogen or CHR8R9, wherein R8 and R9 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and n is 0 or 1.
  2. The composition according to Claim 1, wherein the anaerobic cure-inducing composition comprises a hydroperoxide selected from the group consisting of t-butyl hydroperoxide, p-methane hydroperoxide, cumene hydroperoxide, diisopropylbenzene hydroperoxide, and mixtures thereof.
  3. The composition according to Claim 1, further comprising at least one co-accelerator.
  4. The composition according to Claim 3, wherein the co-accelerator is selected from the group consisting of amines, amine oxides, sulfonamides, metal sources, acids, and mixtures thereof.
  5. The composition according to Claim 3, wherein the co-accelerator is selected from the group consisting of triazines, ethanolamine, diethanolamine, triethanolamine, N,N dimethyl aniline, benzene sulphanimide, cyclohexyl amine, triethyl amine, butyl amine, saccharin, N,N-diethyl-p-toluidine, N,N-dimethyl-o-toluidine, acetyl phenylhydrazine, maleic acid, and mixtures thereof.
  6. The composition according to Claim 1, further comprising at least one stabilizer.
  7. The composition according to Claim 6, wherein the stabilizer is selected from the group consisting of benzoquinone, naphthoquinone, anthraquinone, hydroquinone, methoxyhydroquinone, butylated hydroxy toluene, ethylene diamine tetraacetic acid or a salt thereof, and mixtures thereof.
  8. The composition according to Claim 1, wherein the cure accelerator is
    Figure imgb0023
    wherein R is hydrogen, alkyl, alkenyl, alkynl, hydroxyalkyl, hydroxyalkenyl, or hydroxyalkynl; and R1 and R2 are each individually selected from halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl.
  9. The composition according to Claim 1, wherein the cure accelerator is selected from one or more of
    Figure imgb0024
    Figure imgb0025
    wherein R is as defined above.
  10. The composition according to Claim 1, wherein the cure accelerator is
    Figure imgb0026
    1,2,3,4-tetrahydrobenzo-h-quinolin-3-ol.
EP18782443.8A 2017-10-09 2018-10-04 Cure accelerators for anaerobic curable compositions Active EP3694942B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1716517.6A GB2567242B (en) 2017-10-09 2017-10-09 Anaerobically curable compositions comprising 1, 2, 3, 4-tetrahydro benzo(h)quinolin-3-ol or derivatives thereof
PCT/EP2018/077044 WO2019072686A1 (en) 2017-10-09 2018-10-04 Cure accelerators for anaerobic curable compositions

Publications (2)

Publication Number Publication Date
EP3694942A1 EP3694942A1 (en) 2020-08-19
EP3694942B1 true EP3694942B1 (en) 2021-09-29

Family

ID=60326844

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18782443.8A Active EP3694942B1 (en) 2017-10-09 2018-10-04 Cure accelerators for anaerobic curable compositions

Country Status (11)

Country Link
US (1) US11274190B2 (en)
EP (1) EP3694942B1 (en)
JP (1) JP7312181B2 (en)
KR (1) KR102601879B1 (en)
CN (1) CN111417693B (en)
BR (1) BR112020006459A2 (en)
CA (1) CA3077392A1 (en)
GB (1) GB2567242B (en)
MX (1) MX2020004122A (en)
TW (1) TWI770291B (en)
WO (1) WO2019072686A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116323723A (en) 2020-08-18 2023-06-23 汉高股份有限及两合公司 Curing accelerators for anaerobically curable compositions
WO2023165850A1 (en) * 2022-03-04 2023-09-07 Henkel Ag & Co. Kgaa Cure accelerator for anaerobic curable composition

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218305A (en) 1963-12-26 1965-11-16 Loctite Corp Accelerated anaerobic compositions and method of using same
DE1719144C3 (en) 1967-12-01 1974-08-22 Henkel & Cie Gmbh, 4000 Duesseldorf Accelerated hardening adhesives or sealants in the absence of oxygen
DE1817989C3 (en) 1967-12-28 1981-11-05 Loctite Corp., 06111 Newington, Conn. Method for joining non-porous surfaces by means of polymerizable adhesives
DK126006B (en) * 1969-12-05 1973-05-28 Tokyo Three Bond Co Ltd Anaerobic curing sealing material.
IL36289A (en) * 1970-03-18 1974-03-14 Loctite Corp Highly stable anaerobic compositions comprising acrylate ester monomer
US3970505A (en) 1973-01-15 1976-07-20 Loctite Corporation Anaerobic compositions and surface activator therefor
JPS5247766B2 (en) 1973-08-21 1977-12-05
JPS51132234A (en) * 1975-04-21 1976-11-17 Suriibondo:Kk An anaerobic adhesive composition
US4321349A (en) 1975-05-23 1982-03-23 Loctite Corporation Accelerator for curable compositions
JPS53102989A (en) 1977-02-22 1978-09-07 Denki Kagaku Kogyo Kk Curable composition
JPS5469198A (en) * 1977-11-14 1979-06-02 Toagosei Chem Ind Co Ltd Anaerobic curable composition
DE2911661A1 (en) 1979-03-24 1980-09-25 Bayer Ag METHOD FOR THE PRODUCTION OF THIAZOLIDIN-2-THIONEN
JPS59207977A (en) * 1983-05-12 1984-11-26 Okura Ind Co Ltd Anaerobic adhesive
IE882227L (en) * 1988-07-21 1990-01-21 Loctite Ireland Ltd Sealant composition
US5411988A (en) 1993-10-27 1995-05-02 Bockow; Barry I. Compositions and methods for inhibiting inflammation and adhesion formation
JPH07308757A (en) 1994-05-18 1995-11-28 Tokyo Yogyo Co Ltd Sliding nozzle plate
US5605999A (en) 1995-06-05 1997-02-25 Loctite Corporation Anaerobically curable silicones
US5811473A (en) 1996-04-02 1998-09-22 Loctite Corporation Primer activator composition for anaerobic adhesives
US6001517A (en) * 1996-10-31 1999-12-14 Kabushiki Kaisha Toshiba Positive photosensitive polymer composition, method of forming a pattern and electronic parts
US6043327A (en) 1997-07-03 2000-03-28 Loctite Corporation Anaerobic adhesive compositions of acrylates coreactants and maleimides curable under ambient conditions
WO2000040664A1 (en) 1999-01-08 2000-07-13 Loctite (R & D) Limited Novel curative for anaerobic adhesive compositions
US6852778B1 (en) 1999-06-11 2005-02-08 Three Bond Co., Ltd. Anaerobically curable composition
DE10046024A1 (en) * 1999-09-16 2001-04-19 Yokohama Rubber Co Ltd Reversibly crosslinkable elastomer, used e.g. in recyclable rubber products such as tires and tubing, uses thermoreversible reactions for crosslinking, e.g. between acid anhydride groups and hydroxyl groups
US6958368B1 (en) * 2002-05-31 2005-10-25 Henkel Corporation Cure accelerators for anaerobic curable compositions
US6835762B1 (en) * 2002-05-31 2004-12-28 Henkel Corporation Cure accelerators for anaerobic curable compositions
US6897277B1 (en) * 2003-12-22 2005-05-24 Henkel Corporation Cure accelerators for anaerobic curable compositions
CN100543097C (en) * 2007-05-28 2009-09-23 黑龙江省石油化学研究院 A kind of have low dismounting force moment fire resistant anaerobic adhesive and preparation method thereof
US20090012202A1 (en) * 2007-07-03 2009-01-08 Henkel Corporation Acrylated Urethanes, Processes for Making the Same and Curable Compositions Including the Same
EP2238178B1 (en) * 2008-01-28 2014-09-10 Basf Se Photolatent amidine bases for redox curing of radically curable formulations
CN101497769B (en) * 2009-02-23 2010-11-24 黑龙江省科学院石油化学研究院 Inorganic / organic hybridized high temperature resistant anaerobic type screw thread locking sealing adhesive and preparation thereof
CN102686635B (en) * 2009-05-01 2014-10-22 汉高公司 Cure accelerators for anaerobic curable compositions
ES2537407T3 (en) 2009-05-01 2015-06-08 Henkel US IP LLC Cure accelerators for anaerobic curable compositions
EP2488580B1 (en) 2009-10-15 2015-09-09 Henkel IP & Holding GmbH Anaerobically curable compositions
JP5469198B2 (en) 2012-05-31 2014-04-09 ニチアス株式会社 Insulation
US8945338B2 (en) 2013-03-15 2015-02-03 Henkel US IP LLC Anaerobic curable compositions

Also Published As

Publication number Publication date
MX2020004122A (en) 2020-08-13
TW201922906A (en) 2019-06-16
KR20200067151A (en) 2020-06-11
EP3694942A1 (en) 2020-08-19
JP2020537029A (en) 2020-12-17
GB201716517D0 (en) 2017-11-22
TWI770291B (en) 2022-07-11
KR102601879B1 (en) 2023-11-14
WO2019072686A1 (en) 2019-04-18
GB2567242B (en) 2021-08-11
GB2567242A (en) 2019-04-10
JP7312181B2 (en) 2023-07-20
CN111417693B (en) 2022-05-27
US11274190B2 (en) 2022-03-15
BR112020006459A2 (en) 2020-10-06
CA3077392A1 (en) 2019-04-18
CN111417693A (en) 2020-07-14
US20200299485A1 (en) 2020-09-24

Similar Documents

Publication Publication Date Title
US6835762B1 (en) Cure accelerators for anaerobic curable compositions
US8481659B2 (en) Cure accelerators for anaerobic curable compositions
EP3209702B1 (en) Anaerobic curable compositions having novolac vinyl esters
US20120231286A1 (en) Anaerobically curable compositions
US7411025B1 (en) Cure accelerators for anaerobic curable compositions
US11274190B2 (en) Cure accelerators for anaerobic curable compositions
US9969690B2 (en) Cure accelerators for anaerobic curable compositions
US8519023B2 (en) Fast,curing two part anaerobic adhesive composition
EP3204461B1 (en) Cure accelerators for anaerobic curable compositions
US9969863B2 (en) Cure accelerators for anaerobic curable compositions
US10662147B2 (en) Phenylhydrazine/anhydride adducts and anaerobic curable compositions using same
US20230272186A1 (en) Cure accelerators for anaerobic curable compositions
US7709559B1 (en) Cure accelerators for anaerobic curable compositions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602018024373

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: C09J0004000000

Ipc: C08K0005343700

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: C08K 5/3437 20060101AFI20210517BHEP

INTG Intention to grant announced

Effective date: 20210604

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1434180

Country of ref document: AT

Kind code of ref document: T

Effective date: 20211015

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018024373

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211229

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211229

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20210929

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1434180

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210929

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211230

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220129

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220131

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20211031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602018024373

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211004

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211031

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602018024373

Country of ref document: DE

Owner name: HENKEL AG & CO. KGAA, DE

Free format text: FORMER OWNER: HENKEL IP & HOLDING GMBH, 40589 DUESSELDORF, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211031

26N No opposition filed

Effective date: 20220630

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20220811 AND 20220817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211004

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230530

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20181004

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231020

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231026

Year of fee payment: 6

Ref country code: FR

Payment date: 20231026

Year of fee payment: 6

Ref country code: DE

Payment date: 20231020

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210929